Jyong BiotechMENS
13F holders, Q1 2026 (March 31)17holders −2
4new positions
6sold out
1famous investor
$2.15avg. 13F price*
At the end of Q1 2026, 17 institutions reported holding Jyong Biotech Ltd. (MENS) in their 13F filings, down 2 from Q4 2025. 4 opened new positions and 6 sold out. The largest holders were BlackRock, Inc. ($556K), Geode Capital Management, LLC ($138K) and UBS Group AG ($80K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Jyong Biotech Ltd.
- CUSIP
- G83116106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $57K |
| Exits | 6 | $425K |
All 13F filers, Q4 2025 → Q1 2026: 36,727 shares bought and 274,061 shares sold, net −237,334 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| BlackRock, Inc. | 0.00% | Reduce -0.8% | 258,760 | $556K |
| Geode Capital Management, LLC | 0.00% | Reduce -0.2% | 64,232 | $138K |
| UBS Group AG | 0.00% | Reduce -74.3% | 37,363 | $80K |
| Millennium Management | 0.00% | Reduce -63.8% | 14,590 | $31K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | New | 13,927 | $30K |
| China Universal Asset Management Co., Ltd. | 0.00% | Add +6.3% | 13,173 | $28K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +144.6% | 11,703 | $25K |
| HRT Financial LP | 0.00% | New | 11,767 | $25K |
| Morgan Stanley | 0.00% | Reduce -77.6% | 6,301 | $14K |
| Barclays PLC | 0.00% | Add +46.6% | 5,189 | $11K |
| JPMorgan Chase & Co. | 0.00% | Reduce -6.2% | 5,679 | $11K |
| Mirae Asset Global Investments Co., Ltd. | 0.00% | Add +4.8% | 3,872 | $8K |
| Citigroup Inc. | 0.00% | Reduce -74.4% | 2,787 | $6K |
| BNP Paribas Financial Markets | 0.00% | Add +44.7% | 1,881 | $4K |
| GF Fund Management Co. LTD. | 0.00% | Add +12.3% | 1,677 | $4K |
| Bell Investment Advisors, Inc | 0.00% | New | 473 | $1K |
| Royal Bank of Canada | 0.00% | New | 266 | $1K |
"% of holder's portfolio" is MENS's weight in each manager's 13F, not the share of Jyong Biotech Ltd. the manager owns.